CSX ASX Week ended 31 Jul 2026

Weekly Investor Report

Name: CSX weekly investor report
Creator: Sharemaestro
License: https://sharemaestro.com/data-license/

CleanSpace Holdings Limited · Healthcare · Medical Devices

Open interactive chart View report data

Latest close 0.41 AUD

2.5% latest week

Weekly setup

Mixed setup

The weekly trend is not active. Price is -16.2% below the Trend Line and sits at 12.0% of its 52-week range. The latest completed week returned 2.5%, after a 1.3% four-week move. The latest factor snapshot indicates quality ranks weakly versus its universe; growth ranks strongly; valuation is inexpensive relative to peers. The latest news-sentiment score is 51/100.

Setup score 36 out of 100

Latest Close 0.41 AUD 31 Jul 2026

1W Return 2.5% latest completed week

4W Return 1.3% short-term follow-through

12W Return -1.2% quarterly tape

Trend Breadth 34.6% 18 of 52 weeks active

Volume Ratio 4.1x vs 13-week average

What is working

Activity pressure is positive on the latest completed week.
Volume is elevated versus the 13-week average, confirming attention.

What could go wrong

The trend backdrop is inactive, so price action has not confirmed a constructive regime.
Price is below the Trend Line, which keeps downside pressure in focus.
Price is below Fair Value, so the market is still discounting the latest tape.
Next-week expectancy is negative at 33.74% based on similar historical setup states.

What to watch next

Trend Line remains the key weekly regime level.
Activity pressure is the gauge to monitor for confirmation or fade.
A volume ratio above 1.5x would show stronger participation in the next move.

Price follow-through 2.5% Latest completed week; four-week move 1.3%. Indicator stack 19/66 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Next-Week Expectancy Negative 33.74% Historical one-week expectancy contributes to the evidence score when direction is confirmed. News sentiment 51/100 13 relevant articles in the latest sentiment read.

01 · Price action

Where price is—and whether the trend supports it

The weekly trend is not active. Price is -16.2% below the Trend Line and sits at 12.0% of its 52-week range. The latest completed week returned 2.5%, after a 1.3% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value

Price Trend Line Fair Value

Position in the 52-week range

Close Trend Fair

0.34 AUD 12.0% 0.88 AUD

Range location12.0%Shows where the latest close sits between the 52-week low and high.

Trend distance-16.2%Price premium or discount versus the weekly Trend Line.

Fair-value gap-10.5%Premium demand or model discount versus Sharemaestro Fair Value.

High-water gap-54.0%Distance from the latest 52-week high.

02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 4.1x the 13-week average. Participation is unusually strong and confirms that the move is attracting attention.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction

6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul

Up week Down week

Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.0512-week average 0.02

12-week confirmation

Trend active0/12Active trend-backdrop weeks in the latest 12-week window.

Positive pressure5/12Weeks with constructive activity pressure in the latest 12-week window.

Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.

Activity pressure0.05Current proprietary activity-pressure read.

Buy signals0Accumulation signal count in the latest 12 weeks.

Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 1.3% over four weeks, -1.2% over 12 weeks, and -47.1% over one year. The current trend has remained active for 0 consecutive weeks.

Performance by holding period

1W2.5%

4W1.3%

12W-1.2%

26W-38.6%

52W-47.1%

Active trend streak0 weeks

Active weeks in one year18

Trend breadth34.6%

Activity pressure vs relative leadership

Activity pressureRelative leadership

Pressure0.37Latest activity-pressure read.

Pressure change120.9%Four-week change in activity pressure.

Leadership-31.99Latest relative-leadership reading.

RS change6.5%Four-week change in relative leadership.

04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality ranks weakly versus its universe; growth ranks strongly; valuation is inexpensive relative to peers.

Open full factor analysis

Factor week 26 Jul 2026 Financial statements through 30 Jun 2025 Field coverage 70% Model confidence 37%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength44/100Blend of value, momentum, and quality. Underlying universe rank 57; rank 1 is best.

Value85/100Relative valuation strength. Underlying universe rank 16; rank 1 is best.

Quality12/100Profitability and accounting quality. Underlying universe rank 89; rank 1 is best.

Momentum6/100Medium-term price momentum. Underlying universe rank 95; rank 1 is best.

Growth92/100Revenue and earnings growth. Underlying universe rank 9; rank 1 is best.

How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E: -
Price / sales: 1.6x
EV / EBITDA: -
Free-cash-flow yield: 2.9%

Business quality

Margins and the return generated on invested capital.

Gross margin: 74.8%
Operating margin: -7.7%
Free-cash-flow margin: 5.1%
Return on invested capital: -5.4%

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth: 25.7%
EPS growth: -
Free-cash-flow growth: -
Piotroski F-score: 5/9

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield: -
Buyback yield: 0.0%
Shareholder yield: 0.0%
Net debt / EBITDA: -43.2x

05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity-

No recent insider transactions are stored for this company.

News sentiment51/100

Weighted news tone is neutral across 13 relevant articles.

2 positive · 10 neutral · 1 negative

Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal

06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings-No event is currently stored.

Options expected move-Nearest-chain priced movement where available.

52-week drawdown-54.0%Distance below the 52-week high.

13-week volatility5.5%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

6 Feb 6 Mar 3 Apr 1 May 29 May 26 Jun 31 Jul

Weeks higher5 of 2616 weeks finished lower.

Best week+14.3%Week of 12 Jun.

Worst week-10.9%Week of 20 Feb.

Latest week+2.5%Week of 31 Jul.

Shape of recent returns

Strong gains2

Modest gains3

Flat weeks5

Modest losses11

Sharp losses5

Recent vol5.5%13-week weekly-return volatility.

Base vol4.9%52-week weekly-return volatility.

Up/down split14/30Count of positive and negative weeks in the 52-week window.

Average skew4.7% / -4.1%Average positive week versus average negative week.

07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

SectorAU Healthcare

4-week rank30 / 100

Group average-5.0%

Trend breadth23.0%

Trend23.0%active weekly trend signals

MD60.0%positive activity pressure

RS24.0%positive relative leadership

Four-week leaders

RHT · ASX45.5%AFP · ASX36.2%TTX · ASX27.4%PTX · ASX25.0%EYE · ASX23.8%

IndustryAU Medical Devices

4-week rank5 / 26

Group average-9.9%

Trend breadth19.2%

Trend19.2%active weekly trend signals

MD38.5%positive activity pressure

RS23.1%positive relative leadership

Four-week leaders

EYE · ASX23.8%OSL · ASX17.8%TRU · ASX8.3%EMV · ASX1.6%CSX · ASX1.3%

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape32/100

Trend, activity pressure, participation, and risk combine to a 32/100 tape read.

Indicator analysis18/100

Latest 12-week confirmation: trend 0/12, activity pressure 5/12, relative leadership 0/12.

Activity pressure 0.05; No reversal markers Next-Week ExpectancyNegative 33.74%

Next-week expectancy is negative with a 33.74% historical one-week setup read.

Adds short-term historical context without overriding trend, activity, or relative leadership. Factors36/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 54; Small Cap Core rank 79 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Sentiment51/100

Weighted news tone is neutral across 13 relevant articles.

Jencay Capital Increases Stake in Cleanspace Holdings to 13.35% Following Share Acquisition Insiders50/100

No recent insider transaction evidence is stored.

Earnings50/100

No stored earnings event is currently attached to this ticker.

Week	Close	Return	Trend Line	Fair Value	Pressure	Leadership	Volume	Trend
31 Jul 2026	0.41 AUD	2.5%	0.48 AUD	0.45 AUD	0.37	-31.99	378.2K	Off
24 Jul 2026	0.40 AUD	5.3%	0.49 AUD	0.45 AUD	0.29	-32.97	21.6K	Off
17 Jul 2026	0.38 AUD	-6.3%	0.50 AUD	0.45 AUD	0.23	-37.08	33.5K	Off
10 Jul 2026	0.40 AUD	0.0%	0.51 AUD	0.45 AUD	0.21	-33.64	53.2K	Off
3 Jul 2026	0.40 AUD	0.0%	0.52 AUD	0.45 AUD	0.17	-34.23	295.9K	Off
26 Jun 2026	0.40 AUD	-2.4%	0.53 AUD	0.45 AUD	-0.27	-33.85	18.4K	Off
19 Jun 2026	0.41 AUD	2.5%	0.54 AUD	0.45 AUD	-0.68	-33.02	2.1K	Off
12 Jun 2026	0.40 AUD	14.3%	0.54 AUD	0.45 AUD	-1.06	-34.45	87.2K	Off
5 Jun 2026	0.35 AUD	-9.1%	0.56 AUD	0.44 AUD	-1.40	-41.48	121.1K	Off
29 May 2026	0.39 AUD	-3.8%	0.57 AUD	0.44 AUD	-1.48	-36.53	0	Off
22 May 2026	0.40 AUD	0.0%	0.58 AUD	0.44 AUD	-1.43	-33.62	22.0K	Off
15 May 2026	0.40 AUD	-2.4%	0.59 AUD	0.44 AUD	-1.41	-33.58	92.0K	Off
8 May 2026	0.41 AUD	-2.4%	0.60 AUD	0.44 AUD	-1.44	-32.96	73.8K	Off
1 May 2026	0.42 AUD	-3.4%	0.61 AUD	0.44 AUD	-1.45	-31.28	95.6K	Off

How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.